Cystatin C proteoforms in chronic kidney disease.
Helene DahlKlaus MeyerKristina SandnesNatasha Lervaag WellandIselin ArnesenHans-Peter MartiJutta DierkesVegard LysnePublished in: PloS one (2023)
The different proteoforms of cystatin C increased proportionally with total cystatin C in patients with chronic kidney disease. Prescription of corticosteroids and immunosuppressants had a significant effect on the distribution of proteoforms. The biological significance of these proteoforms remains to be determined.
Keyphrases